Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


Inflammation, Microbiota, and Cancer

19 Sep 2013 - 20 Sep 2013 - National Institutes of Health, Bethesda, MD, USA



Bookmark and Share


The Center for Cancer Research at the National Cancer Institute is hosting a two-day national symposium entitled “Inflammation, Microbiota, and Cancer.”  The program includes recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of cancer and inflammation.

Learn about the latest findings from experts in the field. Sessions and speakers include:

Inflammation and Microbiota

Fiona Powrie, Julie Segre, Heidi Kong, Yasmine Belkaid, Giorgio Trinchieri, Jay Berzofsky 

Cancer,  Microbiota,  and Metabolism

Stephen Hursting, Cari Meinhold Kitahara, Bin Goa, Alfred Goldberg, Luigi Ferrucci, Martin Blaser 

miRNAs, Cancer and Inflammation

Carlo Croce, Curt Harris, Xin Wang, Shyam Sharan, Howard Young, Kevin Struhl, Stuart Yuspa, Yinling Hu

Colon Cancer, Inflammation and Immunity

Raymond Dubois, Jerome Galon, Myriam Merad, Thirunula-Devi Kanneganti, Richard Flavell, Tyler Jacks


Registration is free, but seating is limited so be sure to register early! 

Online registration can be found at: http://ncifrederick.cancer.gov/events/microbiota/default.asp 



Further information
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!